Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

SIGA vs VERU: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SIGA Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 5–5 Matrix Metrics)

SIGA Overall Winner 6-Pillar Tally: SIGA 4 – 2 VERU Matrix Metrics: SIGA 5 – 5 VERU

As of Nov 19, 2026, SIGA Technologies Inc. (SIGA) is the stronger overall head-to-head candidate over Veru Inc. (VERU) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Balance Sheet & Cash Flow, Options & Positioning). SIGA carries a Unified Composite Score of 47.5/100 (HOLD) at $2.65 (2.5x Forward P/E, -14.2% operating margin), whereas VERU carries 54.3/100 (HOLD) at $2.11 (117.7x Forward P/E, 0.0% operating margin).

  • Composite vs. Pillar Nuance: While VERU currently prints a higher short-term Unified Composite Score (54.3/100 HOLD vs. SIGA 47.5/100 HOLD), SIGA captures the overall institutional head-to-head verdict (5–5 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-14.2% vs. 0.0% operating margin) and revenue trajectory (-49.7% vs. +18.3% YoY).
  • Technical & Structure Timing Caution: SIGA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0); meanwhile VERU is in a Breakdown options structure phase (RSI 45.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SIGA vs VERU
SIGA NASDAQ Head-to-Head Winner
SIGA Technologies Inc.
Pharmaceutical Preparations
$2.65
-5.36% 1D
Market Cap $187.9M
TTM Revenue $52M
Forward P/E 2.5x
Beta / 30D Vol 0.75β · 65% Vol
Unified Composite Score
47.5 / 100 HOLD
Tech 40.0 Fund 56.0 Flow 69.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -0.7%), weak momentum, RSI 36
RSI-14: 36.0 · SMA20: $3.02 · SMA50: $3.14
VERU NASDAQ
Veru Inc.
Pharmaceutical Preparations
$2.11
-8.66% 1D
Market Cap $36.4M
TTM Revenue $17M
Forward P/E 117.7x
Beta / 30D Vol 1.78β · 53% Vol
Unified Composite Score
54.3 / 100 HOLD
Tech 38.0 Fund 57.0 Flow 70.0 Mom 54.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 45.4 · SMA20: $2.17 · SMA50: $2.32

6-Pillar Scorecard Institutional Category Breakdown (SIGA 4 – 2 VERU)

Columns: Metric · SIGA · VERU
1. Valuation Multiples SIGA
Forward P/E 2.5x 117.7x
Trailing P/E N/M 117.7x
PEG Ratio 3.37x 3.60x
EV / Revenue 1.4x 0.9x
2. Growth & Scale VERU
Revenue Growth (YoY) -49.7% +18.3%
Earnings Growth (YoY) -65.3% +0.0%
TTM Revenue (USD) $52M $17M
Market Cap $187.9M $36.4M
3. Profitability & Quality VERU
Gross Margin 23.4% 34.7%
Operating Margin -14.2% 0.0%
Net Profit Margin 1.3% 0.0%
Return on Equity (ROE) 0.4% -64.5%
4. Balance Sheet & Cash Flow SIGA
Cash Generation (TTM) -$12M -$26M
Cash Flow Margin -22.1% N/A
Net Cash / Leverage $116M Net Cash $21M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning SIGA
Options Structure Phase CONSOLIDATION BREAKDOWN
Current IV / %ile 81.4% (8th %ile) 74.7% (10th %ile)
Put/Call OI Skew 0.04x (Call-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat SIGA
OpEx & R&D Intensity 37.6% of Rev ($20M) 34.7% of Rev ($5.9M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Drug Manufacturers - Specialty & Generic Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SIGA (5) vs VERU (5)
Institutional Metric SIGA VERU Criterion Row Edge
Market Capitalization
Scale
$187.9M $36.4M Larger Scale SIGA
Trailing P/E Ratio
Valuation
N/M 117.7x Lower Multiple VERU
Forward P/E Ratio
Valuation
2.5x 117.7x Lower Multiple SIGA
Revenue Growth (YoY)
Growth
-49.7% +18.3% Higher Growth VERU
Operating Margin (TTM)
Profitability
-14.2% 0.0% Higher Margin VERU
Net Profit Margin
Profitability
1.3% 0.0% Higher Margin SIGA
Return on Equity (ROE)
Capital Efficiency
0.4% -64.5% Higher ROE SIGA
52-Week Range Position
Momentum
3% ($3–$7) 2% ($2–$7) Stronger Trend SIGA
Beta / 30D Volatility
Risk Regime
0.75β · 65% Vol 1.78β · 53% Vol Lower Realized Risk VERU
Unified Institutional Score
Composite Signal
47.5 / 100 (HOLD) 54.3 / 100 (HOLD) Higher Composite VERU
Trailing 12M Revenue (USD)
Operating Scale
$52M $17M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
23.4% 34.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
3.37x PEG · 1.4x EV/Rev 3.60x PEG · 0.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$12M ($116M Net Cash) -$26M ($21M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon VERU +6.8 pp
SIGA: -15.06% · VERU: -8.26%
3M Horizon SIGA +7.25 pp
SIGA: -12.83% · VERU: -20.08%
6M Horizon VERU +38.79 pp
SIGA: -43.74% · VERU: -4.95%
1Y Horizon VERU +39.01 pp
SIGA: -55.61% · VERU: -16.6%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period SIGA Revenue VERU Revenue SIGA Op. Margin VERU Op. Margin Margin Leader
FY2018 $480M $20M 74.4% -131.6% SIGA
FY2019 $30M $30M -8.7% -20.2% SIGA
FY2020 $120M $40M 67.6% -34.6% SIGA
FY2021 $130M $60M 66.7% 21.2% SIGA
FY2022 $110M $40M 38.5% -212.1% SIGA
FY2023 $140M $20M 59.8% -575.5% SIGA
FY2024 $140M $20M 50.4% -214.2% SIGA
FY2025 $90M N/A 25.1% N/A SIGA

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SIGA CONSOLIDATION
33d in phase · OBV DISTRIBUTION
Current IV 81.4%
IV Percentile 8th %ile
Put/Call OI Skew 0.04x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact SIGA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
VERU BREAKDOWN
117d in phase · OBV NEUTRAL
Current IV 74.7%
IV Percentile 10th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact VERU Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SIGA Moat Profile Cyclical / Execution-Driven Positioning
Drug Manufacturers - Specialty & Generic Operator
Competes within the Drug Manufacturers - Specialty & Generic value chain with $187.9M market capitalization and -14.2% operating margin.
OpEx & R&D Reinvestment 37.6% of Rev ($20M)
90D Engineering Disclosures 0 Published
VERU Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $36.4M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment 34.7% of Rev ($5.9M)
90D Engineering Disclosures 0 Published

Investor FAQ SIGA vs VERU Key Questions & Quantitative Answers

As of Nov 19, 2026, SIGA Technologies Inc. (SIGA) is the stronger overall head-to-head candidate over Veru Inc. (VERU) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Balance Sheet & Cash Flow, Options & Positioning). SIGA carries a Unified Composite Score of 47.5/100 (HOLD) at $2.65 (2.5x Forward P/E, -14.2% operating margin), whereas VERU carries 54.3/100 (HOLD) at $2.11 (117.7x Forward P/E, 0.0% operating margin). Composite vs. Pillar Nuance: While VERU currently prints a higher short-term Unified Composite Score (54.3/100 HOLD vs. SIGA 47.5/100 HOLD), SIGA captures the overall institutional head-to-head verdict (5–5 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-14.2% vs. 0.0% operating margin) and revenue trajectory (-49.7% vs. +18.3% YoY). Technical & Structure Timing Caution: SIGA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0); meanwhile VERU is in a Breakdown options structure phase (RSI 45.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

VERU leads the Growth & Scale pillar: SIGA posts -49.7% YoY revenue growth and -65.3% YoY earnings growth on $52M TTM revenue (23.4% gross margin, -14.2% operating margin), compared with VERU at +18.3% YoY revenue growth and +0.0% YoY earnings growth on $17M TTM revenue (34.7% gross margin, 0.0% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), SIGA cumulative revenue shifted -81.2% while VERU shifted +0.0%. In operating R&D and SG&A reinvestment, SIGA deploys 37.6% of Rev ($20M) (0 90-day corporate R&D disclosures) versus 34.7% of Rev ($5.9M) (0 disclosures) for VERU.

SIGA screens cheaper on headline valuation multiples. SIGA trades at 2.5x Forward P/E, N/M Trailing P/E, 3.37x PEG, and 1.4x EV/Revenue (-22.1% FCF margin), whereas VERU trades at 117.7x Forward P/E, 117.7x Trailing P/E, 3.60x PEG, and 0.9x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SIGA (0.4% ROE) versus VERU (-64.5% ROE) capital efficiency.

In options market volatility and institutional positioning, SIGA carries 81.4% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.04x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.75β · 65% Vol realized risk). By comparison, VERU carries 74.7% implied volatility (10th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (1.78β · 53% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.